BMC Systems Biology · 2012 · 29 citations · 34 references
Life SciencesBioinformaticsPharmacologyDrug DiscoveryPharmacoinformaticsSystems PharmacologyComputational Drug DiscoveryDrug-target Interaction NetworksNetwork MedicineNetwork PharmacologyDrug Combination Network AnalysisDrug Combination PredictionNetwork-based Drug DiscoveryNetwork-based ModelingSynergistic Drug CombinationsTopological Features
BACKGROUND: Combination of different agents is widely used in clinic to combat complex diseases with improved therapy and reduced side effects. However, the identification of effective drug combinations remains a challenging task due to the huge number of possible combinations among candidate drugs that makes it impractical to screen putative combinations. RESULTS: In this work, we construct a 'drug cocktail network' using all the known effective drug combinations extracted from the Drug Combination Database (DCDB), and propose a network-based approach to investigate drug combinations. Our results show that the agents in an effective combination tend to have more similar therapeutic effects and share more interaction partners. Based on our observations, we further develop a statistical approach termed as DCPred (Drug Combination Predictor) to predict possible drug combinations by exploiting the topological features of the drug cocktail network. Validating on the known drug combinations, DCPred achieves the overall AUC (Area Under the receiver operating characteristic Curve) score of 0.92, indicating the predictive power of our proposed approach. CONCLUSIONS: The drug cocktail network constructed in this work provides useful insights into the underlying rules of effective drug combinations and offer important clues to accelerate the future discovery of new drug combinations.
34
An introduction to ROC analysis
Tom Fawcett · Pattern Recognition Letters · 2005 · 21.3K citations
The Structure and Function of Complex Networks
Michael Newman · SIAM Review · 2003 · 18.7K citations · Full text
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text
Medicine, Oncology, Pharmacology +16
Specificity and Stability in Topology of Protein Networks
Sergei Maslov, Kim Sneppen · Science · 2002 · 3.1K citations · Full text